Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
African Countries Aim To Educate People About Tobacco’s Harmful Effects

Phys.org: Six African Countries Gather to Improve Tobacco Counter Marketing “Health Ministry Representatives from Botswana, Kenya, Nigeria, Rwanda, South Africa and Uganda [Tuesday] joined a regional workshop to improve warnings on cigarette packs and anti-tobacco public education campaigns. … Every country represented at the workshop is a party to WHO’s…

Local Research Should Be Applied To NTD Efforts In Indonesia, Scientists Say

SciDev.net: Diseases could stymie Indonesia’s future growth “Now among the world’s twenty largest economies, Indonesia may encounter threats to its future growth owing to currently high rates of neglected tropical diseases (NTDs) afflicting its citizens, a journal article warns…” (Rochmyaningsih, 3/18).

MSF Releases Briefing Paper On Drug-Resistant TB

Médecins Sans Frontières (MSF) released a new briefing paper on Monday which “outlines why the alarming spread of deadly strains of drug-resistant tuberculosis (DR-TB) is one of the biggest global health threats we face today. [The paper] calls on governments, pharmaceutical companies, and researchers to mobilize urgently to save more…

Gates Asserts That Philanthropy, Progress Depend On Innovation

News outlets report on comments by Bill Gates at events in Washington, D.C., this week. The Atlantic: Bill Gates: ‘The Idea That Innovation Is Slowing Down Is … Stupid’ “Bill Gates is aware that there’s a lot of gridlock in Washington. He’s just not sure it matters all that much…

Pharma Companies Need Better Incentives, Innovation To Invest In Neglected Diseases

EurActiv.com: Pharma firms pressed to tackle neglected diseases in developing world “Poverty-related and neglected diseases (PRNDs) disproportionately affect the world’s poorest populations. Better incentives are needed for pharmaceutical companies to develop drugs, health campaigners say. Europe plays a critical role in developing new PRND products that are saving millions of…

Cipla Could Provide Open Access To Patent For First-Line ARV

LiveMint: Cipla may put patent for new HIV drug in open access pool “Cipla Ltd, which competed with multinational drug firms by cutting HIV treatment cost to a fraction of the prevailing rate, is hoping to make a similar impact with a new four-drug combination to treat HIV/AIDS in infants…

GAVI To Support HPV Vaccination Of 1.5M Girls In 3 Countries

Media outlets report on the GAVI Alliance’s announcement that it will support vaccination against human papillomavirus (HPV) for 1.5 million girls in Rwanda, Uganda, and Uzbekistan. UPI: 1.5 million girls in three countries to get HPV shot “An alliance that helps developing nations said it will support vaccination of 1.5…

Arogya World Announces New Global Survey On Women, NCDs

“Arogya World, with partner organizations from multiple sectors, announced [Friday], in advance of International Women’s Day, the start of a global quantitative survey to gather the perspectives of 10,000 women in 10 countries on non-communicable diseases (NCDs). Arogya World and its partners Novartis, Partnership to Fight Chronic Disease, American Cancer…

Hepatitis C Drugs Should Be More Accessible For World’s Poorest

The Guardian: Hepatitis C medicines must be made accessible faster than HIV drugs were Philippe Douste-Blazy, chair of UNITAID and special adviser to the U.N. secretary general on innovative financing “… Until recently, the only cure for hepatitis C involved an expensive combination of injections and tablets that lasted a…

U.S. Expresses Concern Over India’s Proposal To Allow More Generic Drug Production

Reuters: U.S. fears for patents on next-generation drugs in India “The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on…